Patent: 9,358,232

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,358,232

Title:	Methods for treating cancer using TOR kinase inhibitor combination therapy
Abstract:	Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phen- yl)acrylamide to a patient having a cancer.
Inventor(s):	Hege; Kristen Mae (Burlingame, CA), Chopra; Rajesh (Summit, NJ)
Assignee:	Signal Pharmaceuticals, LLC (San Diego, CA)
Application Number:	14/254,010
Patent Claims:	see list of patent claims

Details for Patent 9,358,232

Glossary

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	Try a Free Trial	Signal Pharmaceuticals, LLC (San Diego, CA)	2033-04-17	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,358,232

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Publication Date
Australia	2014254057	Nov 05, 2015
Brazil	112015026021	Jul 25, 2017
Canada	2909579	Oct 23, 2014
China	105339008	Feb 17, 2016
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.